🇺🇸 Plasma-Lyte A In Plastic Container in United States

FDA authorised Plasma-Lyte A In Plastic Container on 2 February 1979

Marketing authorisations

FDA — authorised 2 February 1979

  • Application: NDA017378
  • Marketing authorisation holder: BAXTER HLTHCARE
  • Local brand name: PLASMA-LYTE A IN PLASTIC CONTAINER
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 4 May 1983

  • Application: NDA018893
  • Marketing authorisation holder: HOSPIRA
  • Local brand name: SODIUM ACETATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 30 October 2017

  • Application: ANDA206687
  • Marketing authorisation holder: FRESENIUS KABI USA
  • Local brand name: SODIUM ACETATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 4 May 2021

  • Application: ANDA214805
  • Marketing authorisation holder: MILLA PHARMS
  • Local brand name: SODIUM ACETATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 15 March 2024

  • Application: ANDA216920
  • Marketing authorisation holder: HIKMA
  • Local brand name: SODIUM ACETATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

Read official source →

FDA — authorised 17 April 2026

  • Application: ANDA220274
  • Marketing authorisation holder: EXTROVIS
  • Local brand name: SODIUM ACETATE
  • Indication: SOLUTION — INTRAVENOUS
  • Status: approved

The FDA approved Plasma-Lyte A In Plastic Container for intravenous use on 2026-04-17. This approval was granted to EXTROVIS under the standard expedited pathway. Plasma-Lyte A In Plastic Container is a solution containing sodium acetate, intended for intravenous administration.

Read official source →

FDA

  • Status: approved

Plasma-Lyte A In Plastic Container in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United States

Frequently asked questions

Is Plasma-Lyte A In Plastic Container approved in United States?

Yes. FDA authorised it on 2 February 1979; FDA authorised it on 4 May 1983; FDA authorised it on 30 October 2017.

Who is the marketing authorisation holder for Plasma-Lyte A In Plastic Container in United States?

BAXTER HLTHCARE holds the US marketing authorisation.